Walder Wyss team advised the funds managed by Pharmakon Advisors LP, as leading investor. Novocure (NASDAQ: NVCR) has entered into a new five-year up to $400 million...
You must be a Standard 1 Year member to access this content.
On the deal, Provost is supported by CastaldiPartners and Walder Wyss while the sellers are assisted by Keppeler Avocats. The French group Provost, specialized in the...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised MYTY Group, a portfolio company of Ufenau Capital Partners, on the transaction. The communication agency Agence Trio SA, in Lausanne, has joined the...
You must be a Standard 1 Year member to access this content.
alder Wyss successfully represented Grünenthal Pharma AG before the Swiss Federal Supreme Court. Both the order by the Federal Office of Public Health regarding the price...
You must be a Standard 1 Year member to access this content.
Walder Wyss has represented Digitec Galaxus AG on the dispute. Walder Wyss has represented Digitec Galaxus AG, Switzerland’s largest online store and part of the Migros...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the buyer on the deal. A joint partnership among Trinity Investments, funds managed by Oaktree Capital Management, and funds managed by UBS Asset...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as legal counsel to Swiss Life on this transaction. Swiss Life Holding Ltd. successfully placed three tranches of senior bonds totalling CHF 600...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as Swiss legal advisor for Tango and its US legal advisor Frost Brown Todd LLP. Wenger Vieli acted for Locatee. Tango, a leading...
You must be a Standard 1 Year member to access this content.
Advestra advised Zürcher Kantonalbank on the financing for u-blox Holding AG advised by Walder Wyss. u-blox Holding AG, a global provider of leading positioning and wireless...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Cultivated Biosciences on this transaction. Cultivated Biosciences SA, a Swiss Start-Up developing a creamy, dairy-free and animal free solution/ingredient, has announced the successful...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the ZEDRA Group on Swiss law aspects of the transaction. ZEDRA, a global specialist in Active Wealth, Corporate & Global Expansion, Fund Solutions...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised AFP and MTC on the transaction. Freshfields Bruckhaus Deringer advised MTC on the sale. SIX-listed Aluflexpack AG and Constantia Flexibles, a global packaging manufacturer,...
You must be a Standard 1 Year member to access this content.
